Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-030830
Filing Date
2025-06-11
Accepted
2025-06-11 20:21:17
Documents
4
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749687670.html 4  
1 FORM 4 wk-form4_1749687670.xml 4 8162
2 EX-24 exhibit24wojcickipoa.htm EX-24 4375
3 exhibit24wojcickipoa001.jpg GRAPHIC 247294
4 exhibit24wojcickipoa002.jpg GRAPHIC 32819
  Complete submission text file 0001628280-25-030830.txt   400197
Mailing Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Business Address 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AJAX I HOLDINGS, LLC 667 MADISON AVENUE NEW YORK NY 10606
Business Address
Wojcicki Anne (Reporting) CIK: 0001827709 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 251041412